Christopher Watson Email & Phone Number

Shinjuku-Ku, Tokyo, Jp

Responsible for leading the creation and execution of internal and external investment strategies that generate short, mid and long-term growth opportunities for the corporation. Lead in the identification and prioritization of external investment opportunities, including M&A targets, distribution partnerships and venture investments that will drive current and future growth. Oversee the creation of annual Strategic Business Planning process, focused on prioritizing internal commercial and product development investments made by the corporation. Lead and inspire a team of multi-national marketing Managers and Directors, shaping their personal development and enhancing their cross-functional influence.

Marlborough, Ma, Us

Leadership of Upstream Product Marketing for Boston Scientific's Prostate Cancer and Benign Prostatic Hyperplasia Franchises, resulting in the advancement of New Product Development programs and large Randomized Controlled Trials. In addition, the role oversees the execution of international launch strategy, resulting in >200% planned international growth for 2023. Key Responsibilities and Accomplishments:- Responsible for ensuring that the business maintains the right cadence of innovation and launches to sustain the impressive growth trajectory of 25% YOY. - Manage a team of 4-6 upstream and international Product Managers by inspiring each to execute the annual strategic plan for their respective brand/program, while also focusing on each employee's individual development plan to grow their career. - Key decision maker in cross-functional "Franchise Leadership Team", responsible for the prioritization of new product development programs, multi-year strategic growth plans, and robust global product roadmaps. - Lead team of cross-functional experts to define the go-to-market strategy for novel development programs, including the exploration of R&D, regulatory and clinical requirements to move programs through FDA and global clearances. - Lead global launch strategy across 18 new countries in 2022 (including China, Brazil, Japan), resulting in >200% planned international growth in 2023. - Craft and execute the Prostate Health franchise NPD portfolio strategy by mapping out a cadence of investments made by the franchise over a 10-year period, all supported by well-constructed project proposal, market models, metrics (ROIs, NPVs) and market assumptions.

Marlborough, Ma, Us

Lead the Downstream and Upstream Product Marketing team for BSC’s Prostate Cancer Franchise, resulting in overall revenue growth of 300% from 2019-2021 and the launch of a novel, next-generation product that produced > $100M revenue in the 24-months, post launch. This role also allowed me to optimize my people leadership capabilities in a high-profile and high-growth franchise, by hiring and managing 5 diverse Product Managers to execute the franchise’s multi-channel brand plan.Key Responsibilities and Accomplishments:- Transformed team by replacing legacy Product Managers with a new, hand-picked team of 5 diverse product managers – resulting in overperformance versus Annual Operating Plan.- Oversee the development and subsequent launch of a next-generation product, from R&D exploration through full commercial launch. Over a 24-month period, the product has achieved >65% market share, an ASP uplift of >$300/unit and >$100M in revenue.- Lead creation of annual cross-functional commercial plan for Prostate Cancer Franchise, resulting in the execution of multi-channel tactics for HCPs, patients, sales reps, and value analysis committees.- Spear-head market fortification strategies to prepare for new competitive market entries, resulting in the creation of novel pricing programs, earned purchase capital programs, R&D bench and animal testing, sales training presentations and tactics, and IP/legal strategies. - Create and implement national pricing and rebate strategies to react to procedural reimbursement changes made by Medicare. Despite 12.5% annual declines in office-based reimbursement, franchise average selling price increased by 3% annually due to these strategies. - Identify, validate, and lead the creation of next generation product concepts via R&D and NBD. This requires deep market and customer insights that serve as the foundation for a product investment thesis (Financial Modeling, Pricing, Positioning and “go-to-market” strategy).

Marlborough, Ma, Us

This role leveraged my skill set as an oncology subject matter expert to help refine and define current and future strategies for oncology across three separate, $2B business units within Boston Scientific (Urology, Peripheral Interventions and Endoscopy). This work resulted in major M&A events (acquisition of BTG and Augmenix) and the advancement of two cross-divisional organic programs (Pulsed Electric Fields, Breath Sensor).Key Responsibilities and Accomplishments:- Served as Subject Matter Expert (SME) during the acquisition of BTG ($4.2B). This required leveraging deep KOL relationships to understand existing and future clinical data, conducting blinded VOC using 3rd party vendors, understanding brand preferences and technical product differences to create market and revenue models used during diligence. - Conducted early diligence on numerous companies in GI, Urologic and Hepatic Oncology, resulting in the eventual acquisition of Augmenix ($600M+) and a VC investment in RenovoRX. - Commercial lead for cross-divisional development project to treat lung and brain cancer. This work resulted in the spin-out of the IP into a Medical Device Incubator now chartered with the development of a next-generation device used to treat Glioblastoma. - Commercial lead for cross divisional Breath Sensor program to detect lung cancer. This work led to the execution of an 80-patient FIM study, the development of a Phase III protocol to enable eventual FDA approval, and the creation of a NEWCO to help finance development outside of divisional P&L. - Conceptualized and executed multi-disciplinary Oncology Ad Board. This included the identification and recruitment of 20 physician thought leaders (across 6 physician specialties treating 4 different cancer types), the creation and moderation of all discussion topics and the implementation of feedback toward future divisional strategies.

Marlborough, Ma, Us

Business Development Manager allowed for unprecedented immersion in the financial principles of M&A activities, unique exposure to hundreds of innovative companies seeking acquisition, and deep clinical and technical expertise of Peripheral (Oncology, Venous, Arterial) Interventions, resulting in an acquisition (Celonova Biosciences) and two VC Investments (Veniti, TVA Medical). Key Responsibilities and Accomplishments:- Proactively identify, prioritize, and selectively pursue external opportunities, resulting in the acquisition of Celonova Biosciences ($70M+), Series D investment in Veniti ($25M) and Series C investment in TVA Medical.- Quarterback cross-functional due diligence efforts for M&A, asset acquisition, licensed IP, etc.- Draft, negotiate and implement term sheet for distribution agreements. - Prioritize or disposition incoming M&A opportunities by merging financial, clinical and strategic rigor to assess attractiveness of potential acquisition/partnership. - Own all pre-term sheet financial modelling activities to calculate the NPV, IRR, OI accretion, ROIC, EPS and EBITA for all potential opportunities.

Marlborough, Ma, Us

Overall Summary: This role introduced me to my passion for the field of Oncology and marked my evolution from an experienced upstream and downstream Product Manager into a true subject matter expert with strong leadership capabilities. Key Responsibilities and Accomplishments: Leader of cross-functional new product development teams in Embolics, Coils, and Catheters.  Manage, mentor and coach a team of 2 global downstream Product Managers. Create annual downstream marketing tactical plans for commercialized products. Creation and ownership complex market models for Interventional Oncology Launched 4 new Interventional Oncology products in 5 years.  Conceptualize and execute dedicated franchise physician advisory boards,  Execution of multiple forms of internal and external clinical and technical training 2014 Selected to be a member of “PI 12” – The 12 highest potential employees in the division.

Marlborough, Ma, Us

Overall Summary: During this 4-year time-period, I built a reputation for excellence in Medical Device Product Management, gradually moving into positions of higher-profile for the division.  US launch of the Carotid WALLSTENT and the FilterWire® EZ Embolic Protection System  Marketing lead for all activities related to CABANA post-marketing registry (1000 patients)  Inherited and overcame $10M product backorder through weekly allocation of 12,000 units  Created Integrated Marketing Business Plan for dialysis access and vena cava filtration Execution of 120-day GLP animal study to demonstrate safety of NBD target technology. Upstream development of the Mustang® Dilatation Catheter.  Marketing lead throughout NBD process of due diligence for external technology. 2009 President’s Club winner for “Marketing Excellence”.

Kalamazoo, Mi, Us

Responsible for the downstream global product launch of a metallic segmental replacement product for Orthopaedic Oncology, as well as a biological scaffold designed for soft tissue repair and augmentation.Led OEM collaboration with a biotechnology company in a distribution agreement. Responsibilities included the creation of new product configurations, the negotiation of transfer prices, and the development of clinical trial activities.

Indianapolis, Indiana, Us

Pharmaceutical Sales Representative for Oral and Injectable Diabetes care products Influenced prescribing habits of over 100 physicians in Norristown, PA region through the continual execution of a focused, targeted sales plan.Consistently outperformed quota goals on a quarterly basis, meeting or exceeding national and territorial expectations of over 100% in 2000-2003.

Master Of Business Administration (Mba), Marketing

Bachelor Of Science (Bs), Biology Major, English And Business Minor